| Trial ID: | L5234 |
| Source ID: | NCT04829903
|
| Associated Drug: |
Dulaglutide
|
| Title: |
Dulaglutide Versus Liraglutide in Obese Type 2 Diabetic Adolescents Using Metformin
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Treated With Insulin|Obesity|Adolescent Obesity
|
| Interventions: |
DRUG: Dulaglutide|DRUG: Liraglutide
|
| Outcome Measures: |
Primary: Glycemic level, HbA1c, 24 weeks for the duration of the study|BMI, BMI measurements using weight and height measurements (anthropometric), 24 weeks for the duration of the study|Adverse effects, Recording of adverse effects, 24 weeks for the duration of the study |
|
| Sponsor/Collaborators: |
Sponsor: Corporacion Parc Tauli
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT
|
| Phases: |
|
| Enrollment: |
116
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2020-01-02
|
| Completion Date: |
2021-11-20
|
| Results First Posted: |
|
| Last Update Posted: |
2022-03-14
|
| Locations: |
Zainab Khan, Lahore, Punjab, Pakistan
|
| URL: |
https://clinicaltrials.gov/show/NCT04829903
|
